Dubow Adam
Gen Counsel & Secretary
Dubow Adam has filed 3 SEC Form 4 filings (12 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Apr 23, 2026.
On the most recent filing, Dubow Adam is listed as Gen Counsel & Secretary at Day One Biopharmaceuticals, Inc. Inside the rolling window, Dubow Adam reported no open-market purchases and 2 open-market sales totaling $113K in DAWN. The largest disclosed transaction in the window is a sale of 6,395 DAWN shares on Feb 17, 2026, worth $74K.
Companies traded
Other insiders at DAWN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$113K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Dubow Adam made?
Dubow Adam has filed 3 SEC Form 4 filings (12 transaction rows) across 1 company since 2025.
Which companies does Dubow Adam trade?
Dubow Adam has filed SEC Form 4 disclosures for 1 company, including DAWN.
When was Dubow Adam's most recent SEC Form 4 filing?
Dubow Adam's most recent SEC Form 4 filing on Tracefour is dated Apr 23, 2026.
What is Dubow Adam's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Dubow Adam is listed as Gen Counsel & Secretary.
What is Dubow Adam's total buy and sell value in the current window?
Inside the rolling retention window, Dubow Adam bought $0 and sold $113K based on SEC Form 4 filings.
What was Dubow Adam's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 6,395 DAWN shares on 2026-02-17, worth $74K, per SEC Form 4 filings.